Journal of Virology, March 1999, p. 2350-2358, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Gladstone Institute of Virology and
Immunology1 and
Department of Medicine,
Received 6 July 1998/Accepted 4 November 1998
Binding of the human immunodeficiency virus type 1 (HIV-1) envelope
glycoprotein gp120 to both CD4 and one of several chemokine receptors
(coreceptors) permits entry of virus into target cells. Infection of
tissues may establish latent viral reservoirs as well as cause direct
pathologic effects that manifest as clinical disease such as
HIV-associated dementia. We sought to identify the critical coreceptors
recognized by HIV-1 tissue-derived strains as well as to correlate
these coreceptor preferences with site of infection and dementia
diagnosis. To reconstitute coreceptor use, we cloned HIV-1 envelope V3
sequences encoding the primary determinants of coreceptor specificity
from 13 brain-derived and 6 colon-derived viruses into an isogenic
(NL4-3) viral background. All V3 recombinants utilized the chemokine
receptor CCR5 uniformly and efficiently as a coreceptor but not CXCR4,
BOB/GPR15, or Bonzo/STRL33. Other receptors such as CCR3, CCR8, and
US28 were inefficiently and variably used as coreceptors by various
envelopes. CCR5 without CD4 present did not allow for detectable
infection by any of the tested recombinants. In contrast to the
pathogenic switch in coreceptor specificity frequently observed in
comparisons of blood-derived viruses early after HIV-1 seroconversion
and after onset of AIDS, the characteristics of these V3 recombinants
suggest that CCR5 is a primary coreceptor for brain- and colon-derived
viruses regardless of tissue source or diagnosis of dementia.
Therefore, tissue infection may not depend significantly on viral
envelope quasispeciation to broaden coreceptor range but rather selects
for CCR5 use throughout disease progression.
*
Corresponding author. Mailing address: Gladstone
Institute of Virology and Immunology, P.O. Box 419100, San Francisco,
CA 94110-9100. Phone: (415) 695-3775. Fax: (415) 695-1364. E-mail: mgoldsmith{at}gladstone.ucsf.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|